— Know what they know.
Not Investment Advice

DVTC OTC

Development Technologies Corp.
1W: +19.8% 1M: +19.8% 3M: +20.0% YTD: +20.0% 1Y: +20.0% 3Y: +200.0% 5Y: +51.5%
$6.00
+0.99 (+19.76%)
 
OTC · Financial Services · Shell Companies · Tech Score Buy · Power 72 · $327.0M mcap · Short 80% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$327.0M
52W Range5-6
Volume100
Avg Volume2
Beta3.27
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODaniel Kesonen
SectorFinancial Services
IndustryShell Companies
IPO Date1997-01-02
Websitedvtc.co
4440 PGA Boulevard
Palm Beach Gardens, FL 33410
US
561-626-9901
About Development Technologies Corp.

Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms